• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HeartSciences Inc. - Warrant (NQ:HSCSW)

0.0596 UNCHANGED
Last Price Updated: 3:32 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HeartSciences Inc. - Warrant

< Previous 1 2 3 Next >
News headline image
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
May 19, 2026
Agreement follows Cibolo Health’s endorsement of MyoVista Insights for its network of 127 independent hospitals and reflects continued commercial momentum for HeartSciences’ ECG management platform 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
May 05, 2026
Agreement with St. Vincent Health marks HeartSciences’ transition from early adopter installations to commercial SaaS deployments following the full launch of MyoVista Insights at the American College... 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
April 14, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
March 25, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
March 24, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
March 16, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
February 05, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
January 29, 2026
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
December 15, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
December 11, 2025
Version 1.1 Designed to Provide Best Usability of any ECG System 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
September 11, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Conference Participation and Investor Webinar
August 15, 2025
Virtual Events Include Investor Webinar and Presentation at Emerging Growth Conference 85 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
July 24, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
June 04, 2025
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed for Seamless Integration with Hospital EHR Systems 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
June 03, 2025
Patent covers estimation of measures of heart function using an ECG, which are critical in the diagnosis and early detection of heart disease 
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
May 29, 2025
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
May 20, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
May 08, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
May 07, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
May 01, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Third Quarter Fiscal 2025 Financial Results
March 13, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Inc. Engages Integrous Communications to Enhance Investor Communications
March 10, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results
December 16, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement
November 13, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit
October 14, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results
September 12, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
September 12, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results
July 29, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency
July 26, 2024
From Heart Test Laboratories, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap